Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren’s syndrome

Mesenchymal stem cell (MSCs) transplantation has been used to treat Sjögren’s syndrome (SS) based on the immunoregulatory properties of MSCs. However, the effectiveness need improving and its underlying intrinsic mechanisms remain largely unknown. Here, we show that Id3 is upregulated in bone marrow...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lei, Xu, Junji, Wu, Tingting, Fan, Zhipeng, Sun, Lingyun, Liu, Yi, Li, Yan, Zhang, Chunmei, Wang, Jingsong, Ding, Yaozhong, Wang, Songlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058624/
https://www.ncbi.nlm.nih.gov/pubmed/32139667
http://dx.doi.org/10.1038/s41419-020-2359-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058624/
https://www.ncbi.nlm.nih.gov/pubmed/32139667
http://dx.doi.org/10.1038/s41419-020-2359-6

Ejemplares similares